Compare GLOO & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GLOO | CYRX |
|---|---|---|
| Founded | 2013 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 512.5M | 472.7M |
| IPO Year | 2025 | N/A |
| Metric | GLOO | CYRX |
|---|---|---|
| Price | $6.13 | $10.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $13.75 | $12.83 |
| AVG Volume (30 Days) | 79.7K | ★ 346.0K |
| Earning Date | 12-17-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | $67,523,000.00 | ★ $243,795,000.00 |
| Revenue This Year | $407.93 | N/A |
| Revenue Next Year | $81.48 | $9.12 |
| P/E Ratio | ★ N/A | $8.00 |
| Revenue Growth | ★ 217.17 | 41.27 |
| 52 Week Low | $5.30 | $4.58 |
| 52 Week High | $9.98 | $11.45 |
| Indicator | GLOO | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.62 | 49.93 |
| Support Level | $5.99 | $10.39 |
| Resistance Level | $6.74 | $11.45 |
| Average True Range (ATR) | 0.59 | 0.50 |
| MACD | 0.07 | -0.08 |
| Stochastic Oscillator | 37.50 | 25.32 |
Gloo Holdings Inc is engaged in building a technology platform company. It has provided a breadth of products, services, and solutions to the two primary stakeholders at the core of the faith and flourishing ecosystem: (1) network capability providers (NCPs) and (2) the churches and frontline organizations (CFLs) it serves. The company serves as a digital infrastructure between NCPs and CFLs. By facilitating efficient exchange between the two, Gloo enables both sides to succeed; CFLs gain access to resources and NCPs benefit from efficient distribution and targeted reach. This creates a virtuous cycle, strengthening the platform with each interaction. The Gloo platform includes a suite of technology, marketplace, and service solutions offered directly from Gloo or from Gloo's subsidiaries.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.